Crinetics Pharmaceuticals SG&A Expense (TTM) Analysis

Crinetics Pharmaceuticals Inc (CRNX)

45.54 -0.53 (-1.15%) USD | NASDAQ | Jul 02, 16:00

45.54 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
March 31, 2024	66.73M
December 31, 2023	58.09M
September 30, 2023	52.29M
June 30, 2023	48.73M
March 31, 2023	45.88M
December 31, 2022	42.39M
September 30, 2022	38.48M
June 30, 2022	32.78M
March 31, 2022	27.90M
December 31, 2021	24.52M
September 30, 2021	22.12M
June 30, 2021	20.65M
March 31, 2021	19.37M

Date	Value
December 31, 2020	18.03M
September 30, 2020	16.46M
June 30, 2020	15.62M
March 31, 2020	14.35M
December 31, 2019	13.52M
September 30, 2019	12.69M
June 30, 2019	10.51M
March 31, 2019	8.567M
December 31, 2018	6.659M
September 30, 2018	4.565M
June 30, 2018	3.324M
March 31, 2018	2.598M
December 31, 2017	1.939M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

12.69M

Minimum

Sep 2019

66.73M

Maximum

Mar 2024

31.08M

Average

24.52M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks